Answers are grounded in this paper and cite their sources.
In the present study, it was aimed to demonstrate the antibacterial and synergistic activities of 2-benzoxazolinone, a promising allelochemical, against Klebsiella pneumoniae ATCC 700603, Escherichia coli ATCC 25922, Enterococcus faecalis ATCC 29212, and Staphylococcus aureus ATCC 25923 via broth microdilution method. 2-benzoxazolinone exhibited promising antibacterial activity against all tested bacteria with 4 mg/mL against E. coli and E. faecalis, and K. pneumoniae and S. aureus 2 mg/mL against. When used in combination with ciprofloxacin, no antagonistic activity was observed. However, the combination interaction revealed indifferent activity against all tested strains. Overall, the antibacterial data obtained from the study demonstrated that 2-benzoxazolinone can further be used as a potential antibacterial agent in the treatment of bacterial infections.
No takes yet. Share an insight, caveat, or question.
Ertuğrul Özbil (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: